The Lancet Digital Health
-
1
[Editorial] Epilepsy research in the AI era
-
2
[Articles] Effect of a computer-aided quality feedback system on colonoscopists’ adenoma detection rate in Denmark: a multicentre, stepped-wedge, cluster-randomised, controlled trial
-
3
[Review] Artificial intelligence models for automated and semiautomated analysis and interpretation of clinical electroencephalography
-
4
[Review] Machine learning prediction for epilepsy treatment selection and prognosis: achievements and challenges
-
5
[Articles] Status, challenges, and future directions of machine learning in the management of epilepsy: a systematic review and meta-analysis
-
6
[Articles] Multimodal artificial intelligence-based long-term mortality prediction after transcatheter aortic valve implantation: a multicentre development, validation, and testing study
-
7
[Articles] Performance and label efficiency of traditional deep-learning models and a retina-specific foundation model for ocular and systemic disease detection: a retrospective comparative study
-
8
[Comment] Power, governance, and accountability in humanitarian artificial intelligence
-
9
[Comment] Need for ethical use of artificial intelligence in humanitarian data collection to address aid shortfalls
-
10
[Articles] Toward unified and comprehensive automated electroencephalogram interpretation: a multicentre development and validation of an electroencephalogram foundation model
The Lancet Gastroenterology & Hepatology
-
1
[Corrections] Correction to Lancet Gastroenterol Hepatol 2025; 10: 537–49
-
2
[News] Research in Brief
-
3
[Editorial] Baveno VIII: what's new?
-
4
[Correspondence] Validation of Rome V for irritable bowel syndrome
-
5
[Correspondence] Tackling the global liver disease syndemic through primary care in the Asia-Pacific region
-
6
[Correspondence] Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer
-
7
[Correspondence] Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer
-
8
[Correspondence] Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer
-
9
[Correspondence] Lessons from the TRIPLET-HCC trial
-
10
[Correspondence] Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer – Authors’ reply
The Lancet Global Health
-
1
[Editorial] Children with arthritis: orphans of the NCD agenda?
-
2
[Viewpoint] Beyond monitoring misery during conflict: the political economy of global health reform
-
3
[Articles] Hypoxaemia and mortality in children with lower respiratory infection in low-income and middle-income countries: systematic review and meta-analysis
-
4
[Comment] Economic case for universal hepatitis B birth dose vaccination in South Africa
-
5
[Articles] Cost-effectiveness of the hepatitis B birth-dose vaccine in South Africa: a mathematical modelling analysis
-
6
[Correspondence] Beyond geography: conflict, displacement, and structural vulnerability in noma distribution in Nigeria
-
7
[Correspondence] Beyond geography: conflict, displacement, and structural vulnerability in noma distribution in Nigeria
-
8
[Correspondence] How to find panellists for a global health conference
-
9
[Correspondence] Structural silencing and the elephant in the room in global health
-
10
[Correspondence] Global health and its crises: laugh, but then what?
The Lancet Haematology
-
1
[Correspondence] Should plasma cell leukaemia be classified as multiple myeloma?
-
2
[In Focus] From pain to purpose: my thalassaemia journey
-
3
[Clinical Picture] Rethinking the possibilities of adult ring sideroblastic anaemia
-
4
[Series] Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration
-
5
[Comment] Rethinking anti-BCMA T-cell engager design
-
6
[In Focus] From survival to self-determination: the chronic warrior
-
7
[Comment] Bridging the thalassaemia divide in south and southeast Asia
-
8
[Comment] α-thalassaemia: an overlooked disease entering a new era
-
9
[Series] The expanding therapeutic landscape of β-thalassaemia
-
10
[Editorial] Thalassaemia revisited: whose progress?
The Lancet Healthy Longevity
-
1
[Editorial] Making dementia clinical trials more representative
-
2
[Articles] Social connection and intrinsic capacity in later life across the USA, England, Europe, China, and Japan: a harmonised multicohort longitudinal study
-
3
[Comment] Hearing loss, hearing aids, and longevity: from association to intervention
-
4
[Articles] Hearing loss, hearing-aid use, and mortality risk: individual participant data meta-analysis of population-based studies from Australia, Iceland, and the USA and a replication study from Norway
-
5
[Comment] Healthy ageing for all? Socioeconomic inequalities in intrinsic capacity across generations
-
6
[Articles] Cohort trends in intrinsic capacity in Europe: a population-based longitudinal study
-
7
[Articles] RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial
-
8
[Articles] Effect of pre-existing dementia on cancer-specific and all-cause mortality in patients with cancer in Denmark: a population-based cohort study
-
9
[Personal View] Sarcopenia as a manifestation of systemic energetic failure with ageing
-
10
[Feature] Highlights of AAIC 2026
The Lancet HIV
-
1
[Corrections] Correction to Lancet HIV 2026; 13: e569–610
-
2
[Review] The present and future of HIV and viral hepatitis co-infection
-
3
[Corrections] Correction to Lancet HIV 2026; 13: e30–39
-
4
[Editorial] Fiji's national HIV emergency
-
5
[Culture] Using circus skills to tell stories about HIV/AIDS
-
6
[Articles] Epidemiological trends of HIV among individuals aged 15–54 years in South Africa from 2004 to 2025: a population-based, longitudinal cohort study
-
7
[Articles] Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study
-
8
[Articles] Virological failure and treatment interruption among people with unsuppressed viral load on antiretroviral therapy: a cross-sectional analysis of Population-based HIV Impact Assessment surveys in seven sub-Saharan African countries
-
9
[Articles] Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study
-
10
[Comment] Low-level viraemia in children living with HIV
The Lancet Infectious Diseases
-
1
[Newsdesk] Increase of West Nile virus cases in Europe
-
2
[Newsdesk] African countries' effort to interrupt polio outbreaks
-
3
[Newsdesk] The 17th annual NTD NGO Network conference
-
4
[Newsdesk] Momentum builds for the global elimination of trachoma
-
5
[Obituary] Vasee Moorthy
-
6
[Newsdesk] Research in brief
-
7
[Profile] Dora Buonfrate—making strongyloidiasis less neglected
-
8
[Editorial] Hope for efficacious vaccines for Bundibugyo virus
-
9
[Clinical Picture] Mucocutaneous leishmaniasis caused by Leishmania infantum in a Norwegian patient receiving TNF-α inhibitor therapy
-
10
[Corrections] Correction to Lancet Infectious Dis; published online Aug 25 https://doi.org/10.1016/S1473-3099(26)00318-X
The Lancet Microbe
-
1
[Editorial] AMR stewardship needs microbiology
-
2
[Comment] Advancing Group A Streptococcus vaccines: barriers, models, and the path to rheumatic fever prevention
-
3
[Series] Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury
-
4
[Articles] Burden and genomic characterisation of Shigella-associated diarrhoea in children younger than 5 years in Lusaka, Zambia: a prospective cohort study
-
5
[Articles] Antibody dynamics after melioidosis infection in Thailand: a retrospective cohort study
-
6
[Articles] Effects of attenuated influenza virus administration to young children on pneumococcal density and acquisition in UK families: a randomised controlled trial
-
7
[Review] From microbiomes to predictive ecosystems: challenges and opportunities in artificial intelligence-based approaches
-
8
[News] Rare Ebola species drives new outbreak
-
9
[Personal View] Learning from inconsistencies: refining biomarker discovery in viral diseases
-
10
[Correspondence] Optimising tongue-swab Xpert MTB/RIF Ultra testing as a diagnostic system
The Lancet Neurology
-
1
[Articles] Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies
-
2
[Comment] The use of blood biomarkers to understand responses to lecanemab treatment
-
3
[Articles] Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study
-
4
[Policy View] Reframing traumatic brain injury and spinal cord injury as chronic multisystem disorders: toward integrated, long-term care
-
5
[Editorial] Neurotrauma as a chronic disease: a call for integrated care
-
6
[In Context] A Ferrier sesquicentenary
-
7
[Articles] Safety and efficacy of delpacibart zotadirsen in Duchenne muscular dystrophy mutations amenable to exon 44 skipping in the USA (EXPLORE44): a randomised, placebo-controlled, double-blind, phase 1/2 trial
-
8
[Comment] From syndrome to antibody-defined autoimmune encephalitides
-
9
[Correspondence] Staged bilateral focused ultrasound pallidothalamic tractotomy for Parkinson's disease
-
10
[Correspondence] Staged bilateral focused ultrasound pallidothalamic tractotomy for Parkinson's disease